Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brooke Story Insider Profile
4 Followers
Brooke Story, Director at Sigilon Therapeutics, holds ― shares in Sigilon Therapeutics (Ticker: SGTX), holds 3.48K shares in LivaNova (Ticker: LIVN). Most recently, Brooke Story ― shares of Sigilon Therapeutics on ― for an estimated value of ―.
Brooke Story Sigilon Therapeutics (SGTX)Director
Sigilon Therapeutics (SGTX)
Director
Not Ranked
Brooke Story has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Brooke Story holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brooke Story
Brooke Story's Trading History
Sigilon Therapeutics
―
―
―
―
LivaNova
Jun 18, 2024
Director
Uninformative Buy
110.42K
$185.79K
List of latest transactions for each holding click on a transaction to see Brooke Story's performance on stock
You May Also Like
Brooke Story insider profile FAQ
What is the percentage of profitable transactions made by Brooke Story?
The percentage of profitable transactions made by Brooke Story is ―.
What is the average return per transaction made by Brooke Story?
The average return per transaction made by Brooke Story is ―.
What stocks does Brooke Story hold?
Brooke Story holds: SGTX, LIVN stocks.
What was Brooke Story’s latest transaction?
Brooke Story latest transaction was an Uninformative Buy of ―.
What was Brooke Story's most profitable transaction?
Brooke Story’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brooke Story's role in Sigilon Therapeutics?
Brooke Story's role in Sigilon Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.